Nusano and Primo Announce Multi-Isotope Supply Agreement

Nusano and Taiwan-based Primo Biotechnology announced a multi-isotope supply agreement to support radiotheranostic development and targeted cancer therapies.
Read the full report on Ein Presswire
Story file
- Section
- Business
- Topics
- Economy & RBI, Health alerts
- First reported by
- Ein Presswire
- Reporter
- sunny chen
- Published
- Wednesday, 14 October 2026, 7:30 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Ein Presswire with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.





